entertainment -WSS

entertainment

author：fashion 2025-10-02 21:36:43 - browse：3

Biogen, a biotech giant plagued by years of boardroom strife, said late Monday that the longtime and polarizing director Alex Denner would step down from its board, sending a signal to investors that the company’s fractious recent history might be coming to a close.

What Biogen didn’t disclose is that its nominee to replace Denner on the board, Susan Langer, is Denner’s live-in romantic partner and the mother of his child, born in November, according to court records obtained by STAT. Denner is in the middle of a protracted divorce from his wife of nearly 25 years, with whom he has two teenage sons — a bitter legal fight in which his extramarital relationship with Langer is a contentious issue, according to the records.

Biogen spokesperson Jack Cox said the company knew about the relationship between Denner and Langer. He also said that Denner recommended Langer to Biogen’s board — he said he incorrectly stated at first that Denner nominated her — but declined to comment on the company’s vetting process and whether it planned to disclose the relationship to shareholders before they vote on Langer’s candidacy later this month. Biogen also omitted mention of the relationship from Langer’s biography in a Securities and Exchange Commission filing Tuesday morning.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Radiation, mainstay of cancer treatment, begins a fade

WSS

Congress might make insulin pumps more accessible to the blind

AstraZeneca bets AAV gene therapy will still deliver the goods

Having children helps parents live longer, especially after age 80

Doctors on social media are being harassed and cyberbullied

Appeals court upholds limits to abortion pill

AMAs digital advisors table RPM coding reform proposal, again

focus

entertainment

focus

BioMarin wins approval for gene therapy to treat hemophilia A

AMAs digital advisors table RPM coding reform proposal, again

Walensky prepares to leave CDC — and Congress — behind

How Long Island became the ‘eugenics capital of the world’

BioMarin wins approval for gene therapy to treat hemophilia A

How to make Best Hospitals ratings actually useful for patients

Moonlake's readout produced a cash windfall. Risks remain

Report cites 'urgent' need to recruit more diverse clinical trial participants

After affirmative action ruling, medical educators look to 'holistic review'

What AAP's gender

explore

Lilly to acquire Dermira for $1.1 billion, adding eczema drug to its pipeline

Here’s what’s in the FDA plan to include pregnant women in clinical trials

Congress might make insulin pumps more accessible to the blind

Readout Newsletter: Replicate, Biogen's Leqembi, and Humira

What AAP's gender

Ebola vaccine can save some who are already sick, per new study

explore

Wikipedia

explore

hotspot